Literature DB >> 546171

Aspirin, salicylate and prostaglandins.

M J Smith, A W Ford-Hutchinson, J R Walker, J A Slack.   

Abstract

The effects of aspirin, salicylic acid and gentisic acid on the paw swellings in the arachidonic acid-potentiated and in the conventional carrageenan-induced oedema tests as well as on the content of prostaglandin-like activity and leucocyte migration in the exudate of inert implanted sponges in the rat have been studied. It is concluded that aspirin exerts two separate inhibitory effects on prostaglandin formation in vivo, a rapid action of the intact molecule on easily accessible tissues and a later action due to its metabolic conversion to salicylic acid. Salicylic acid inhibits prostaglandin biosynthesis in vivo as the salicylate ion itself and there is no formation of a subsequent 'active' metabolite.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 546171     DOI: 10.1007/BF01968116

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  14 in total

1.  The application of paper partition chromatography to the study of the metabolism of salicylate in the rat.

Authors:  E QUILLEY; M J H SMITH
Journal:  J Pharm Pharmacol       Date:  1952-09       Impact factor: 3.765

2.  Multiple sites of interaction between prostaglandins and non-steroidal anti-inflammatory agents.

Authors:  E L Tolman; R Partridge
Journal:  Prostaglandins       Date:  1975-03

3.  Penetration of naproxen and salicylate into inflammatory exudates in the rat.

Authors:  N S Doherty; M Anttila; P B Dean
Journal:  Ann Rheum Dis       Date:  1977-06       Impact factor: 19.103

4.  Salicylic acid fails to inhibit generation of thromboxane A2 activity in platelets after in vivo administration to the rat.

Authors:  B B Vargaftig
Journal:  J Pharm Pharmacol       Date:  1978-02       Impact factor: 3.765

Review 5.  Salicylate and enzymes.

Authors:  M J Smith; P D Dawkins
Journal:  J Pharm Pharmacol       Date:  1971-10       Impact factor: 3.765

6.  The binding of salicylate to plasma proteins in different species.

Authors:  J A Sturman; M J Smith
Journal:  J Pharm Pharmacol       Date:  1967-09       Impact factor: 3.765

7.  Prostaglandins and leucocyte migration in inflammatory reactions.

Authors:  A W Ford-Hutchinson; J R Walker; N S Connor; M J Smith
Journal:  Agents Actions       Date:  1977-10

8.  The effects of antiinflammatory drugs on the production of prostaglandins in vivo.

Authors:  G A Higgs; E A Harvey; S H Ferreira; J R Vane
Journal:  Adv Prostaglandin Thromboxane Res       Date:  1976

Review 9.  Aspirin and prostaglandins: some recent developments.

Authors:  M J Smith
Journal:  Agents Actions       Date:  1978-06

10.  Anti-inflammatory drugs, prostaglandins and leucocyte migration.

Authors:  J R Walker; M J Smith; A W Ford-Hutchinson
Journal:  Agents Actions       Date:  1976-09
View more
  6 in total

1.  [Not Available].

Authors:  E Hackenthal
Journal:  Schmerz       Date:  1990-09       Impact factor: 1.107

2.  Effects of salicylic and acetylsalicylic acid alone and in combination on platelet aggregation and prostanoid synthesis in man.

Authors:  B Rosenkranz; C Fischer; C O Meese; J C Frölich
Journal:  Br J Clin Pharmacol       Date:  1986-03       Impact factor: 4.335

3.  Lipoxygenase products and the polymorphonuclear leucocyte.

Authors:  A W Ford-Hutchinson; M A Bray; M J Smith
Journal:  Agents Actions       Date:  1980-12

4.  Pharmacokinetics of aspirin and salicylate in relation to inhibition of arachidonate cyclooxygenase and antiinflammatory activity.

Authors:  G A Higgs; J A Salmon; B Henderson; J R Vane
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

5.  Is aspirin a prodrug for antioxidant and cytokine-modulating oxymetabolites?

Authors:  D R Haynes; P F Wright; S J Gadd; M W Whitehouse; B Vernon-Roberts
Journal:  Agents Actions       Date:  1993-05

6.  Might salicylate exert benefits against childhood cancer?

Authors:  G Morgan; Ji Johnsen
Journal:  Ecancermedicalscience       Date:  2010-01-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.